Literature DB >> 17643243

Wide excision and ulno-carpal arthrodesis for primary aggressive and recurrent giant cell tumours.

S Bhagat1, M Bansal, R Jandhyala, H Sharma, P Amin, J P Pandit.   

Abstract

Twenty-five patients underwent wide resection of the distal radial giant cell tumours (GCTs) followed by ulno-carpal arthrodesis. There were 15 male and ten female patients, with an average age of 21.5 years. Tumours included ten primary aggressive and 15 recurrent GCTs. Mean follow up was 2.4 years. Pain, swelling and reduced range of movement (ROM) were noted. Average time to fusion was 7.6 months. Five patients had persistent pain in the proximal forearm. Grip strength was 65% compared to the uninvolved side. Two patients had superficial wound infection, two underwent additional bone grafting and three implant removals due to hardware prominence were carried out. There was no evidence of carpal instability or arthritis on clinical or radiological examination at the time of final follow up. Fusion of the carpus to the ulna is a simple method of producing a painless stable wrist, though at the expense of mobility. The procedure allows wide resection with a lower rate of recurrence. Pain in the proximal forearm seems to persist for 3 to 4 months only to improve at subsequent follow up. The procedure provides a valid option for the management of primary aggressive and recurrent GCTs of distal radius.

Entities:  

Mesh:

Year:  2007        PMID: 17643243      PMCID: PMC2898956          DOI: 10.1007/s00264-007-0416-8

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  22 in total

1.  The fate of autogenous and homogenous bone grafts.

Authors:  S W CHASE; C H HERNDON
Journal:  J Bone Joint Surg Am       Date:  1955-07       Impact factor: 5.284

2.  Treatment of giant-cell tumors of long bones with curettage and bone-grafting.

Authors:  H R Blackley; J S Wunder; A M Davis; L M White; R Kandel; R S Bell
Journal:  J Bone Joint Surg Am       Date:  1999-06       Impact factor: 5.284

3.  Giant cell tumour of distal radius replaced by massive fibular autograft: a case report.

Authors:  S M Parker; D E Hastings; V L Fornasier
Journal:  Can J Surg       Date:  1974-09       Impact factor: 2.089

4.  Giant-cell tumor of bone. An analysis of two hundred and eighteen cases.

Authors:  R R Goldenberg; C J Campbell; M Bonfiglio
Journal:  J Bone Joint Surg Am       Date:  1970-06       Impact factor: 5.284

5.  Extensive giant-cell tumor of the lower end of the radius. A report of 1 case treated by resection and replacement with the fibula.

Authors:  H T Sakellarides
Journal:  Clin Orthop Relat Res       Date:  1965 Sep-Oct       Impact factor: 4.176

6.  Reconstruction of the distal radius by fibula following excision of giant cell tumor.

Authors:  V K Aithal; K Bhaskaranand
Journal:  Int Orthop       Date:  2003-01-04       Impact factor: 3.075

7.  Massive resection and allograft transplantation in the treatment of malignant bone tumors.

Authors:  H J Mankin; F S Fogelson; A Z Thrasher; F Jaffer
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

8.  Allograft replacement of distal radius for giant cell tumor.

Authors:  R J Smith; H J Mankin
Journal:  J Hand Surg Am       Date:  1977-07       Impact factor: 2.230

9.  Vascularized fibular graft after excision of giant-cell tumor of the distal radius: wrist arthroplasty versus partial wrist arthrodesis.

Authors:  Akio Minami; Hiroyuki Kato; Norimasa Iwasaki
Journal:  Plast Reconstr Surg       Date:  2002-07       Impact factor: 4.730

10.  One-bone forearm.

Authors:  M E Castle
Journal:  J Bone Joint Surg Am       Date:  1974-09       Impact factor: 5.284

View more
  8 in total

1.  Carpus translocation into the ipsilateral ulna for distal radius recurrence giant cell tumour: A case report and literature review.

Authors:  Athanasios N Ververidis; Georgios I Drosos; Konstantinos E Tilkeridis; Konstantinos I Kazakos
Journal:  J Orthop       Date:  2015-02-21

2.  Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?

Authors:  Robert W Wysocki; Emily Soni; Walter W Virkus; Mark T Scarborough; Sue E Leurgans; Steven Gitelis
Journal:  Clin Orthop Relat Res       Date:  2014-12-04       Impact factor: 4.176

3.  Management of Giant Cell Tumour Radius in a Three Year old Child with an Improvised Technique.

Authors:  Ajay Puri; Vipin Sharma; Ashish Gulia; Seema Sharma; Amit K Verma
Journal:  J Clin Diagn Res       Date:  2014-12-05

4.  Campanacci Grade III Giant Cell Tumors of Distal End Radius Treated With Wide Excision and Reconstruction: A Retrospective Case Series.

Authors:  Eppakayala Srikanth; Nageswara Rao Kancherla; Bodla Arvind; Maheshwar Lakkireddy; Nagesh Cherukuri; Shravan Peddamadyam; Deepak Kumar Maley
Journal:  Cureus       Date:  2022-08-09

5.  Mucor Osteomyelitis of the Distal Radius Necessitating Ulnocarpal Fusion.

Authors:  Ekaterina Tiourin; Melissa Kanack; Wendy Ng; Amber Leis
Journal:  Cureus       Date:  2021-01-20

6.  Retrospective Analysis of Giant Cell Tumor Lower End Radius Treated with En bloc Excision and Translocation of Ulna.

Authors:  Amit Vyas; Purnima Patni; Narender Saini; Rahul Sharma; Vinit Arora; S P Gupta
Journal:  Indian J Orthop       Date:  2018 Jan-Feb       Impact factor: 1.251

7.  Recurrence of Giant Cell Tumor in Fibular Graft Used for Treatment in Primary Giant Cell Tumor of Distal End Radius: A Case Report and Surgical Treatment with Excision of Tumor with Proximal Row Carpectomy with Ulnocarpal Fusion.

Authors:  Rajat Kapoor; Chandra Prakash Pal; Karuna Shankar Dinkar; Yajuvendra Kumar Sharma
Journal:  J Orthop Case Rep       Date:  2020

Review 8.  Centralization of ulna with wrist fusion for failure of reconstructed distal radius by allograft bone or prosthesis: A case report and literature review.

Authors:  Zuchang Li; Yong Yang; Bin Li; Feng Li; Xingjian Huang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.